Jennifer Bush
Nurse Practitioner · Salt Lake City, UTNPI 1760056089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 347 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 24.2% of the total. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$708
- Neurocrine Biosciences, Inc.$586
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$498
- Vanda Pharmaceuticals Inc.$402
- Alkermes, Inc.$322
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,82999%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,663 |
| Johnson & Johnson | 32 | $708 |
| Neurocrine Biosciences, Inc. | 23 | $586 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $498 |
| Vanda Pharmaceuticals Inc. | 17 | $402 |
| Alkermes, Inc. | 16 | $322 |
| Teva Pharmaceuticals USA, Inc. | 24 | $318 |
| Otsuka America Pharmaceutical, Inc. | 16 | $306 |
| Lundbeck LLC | 13 | $263 |
| Corium, LLC | 16 | $244 |
| Axsome Therapeutics, Inc. | 10 | $202 |
| Tris Pharma Inc | 10 | $198 |
| Supernus Pharmaceuticals, Inc. | 10 | $184 |
| Biogen | 8 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $143 |
| Ironshore Pharmaceuticals Inc. | 6 | $113 |
| Sunovion Pharmaceuticals Inc. | 9 | $111 |
| Indivior Inc. | 5 | $91 |
| Braeburn Inc. | 5 | $87 |
| Idorsia Pharmaceuticals US Inc | 5 | $79 |
| Noven Therapeutics, LLC | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Lilly USA, LLC | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $14 |
| Eisai Inc. | 1 | $11 |
How this compares
$6,871 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 25 | $458 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $440 |
| Clonazepam | 12 | $190 |
| Fluoxetine Hcl | 11 | $123 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Salt Lake City
- Julia BattenSalt Lake City$223K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$13K
- Dana ShawSalt Lake City$10K
- Samantha AbertonSalt Lake City$10K
- Stacy ParrySalt Lake City$6K
- Krystal BischoffSalt Lake City$5K
- Jennifer UrchSalt Lake City$5K
- Millie DorseySalt Lake City$5K
- Diane RussellSalt Lake City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.